Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)

BACKGROUND: To describe the patterns of second-line treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel treatment in a Spanish population, to identify the factors associated with those patterns, and to compare the efficacy and safety of the treatments m...

Descripción completa

Detalles Bibliográficos
Autores principales: Puente, Javier, González-del-Alba, Aranzazu, Sala-Gonzalez, Núria, Méndez-Vidal, María José, Pinto, Alvaro, Rodríguez, Ángel, Cuevas Sanz, José Miguel, Muñoz del Toro, Jacobo Rodrigo, Useros Rodríguez, Eduardo, García García-Porrero, Ángela, Vázquez, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683519/
https://www.ncbi.nlm.nih.gov/pubmed/31382926
http://dx.doi.org/10.1186/s12885-019-5974-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683519/
https://www.ncbi.nlm.nih.gov/pubmed/31382926
http://dx.doi.org/10.1186/s12885-019-5974-9

Ejemplares similares